- Home
- PFE vs WELL Comparison
PFE vs WELL Comparison
Compare PFE & WELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFE
- WELL
- Stock Information
- Founded
- PFE 1849
- WELL 1970
- Country
- PFE United States
- WELL United States
- Employees
- PFE N/A
- WELL N/A
- Industry
- PFE Biotechnology: Pharmaceutical Preparations
- WELL Real Estate Investment Trusts
- Sector
- PFE Health Care
- WELL Real Estate
- Exchange
- PFE Nasdaq
- WELL Nasdaq
- Market Cap
- PFE 134.2B
- WELL 111.2B
- IPO Year
- PFE N/A
- WELL N/A
- Fundamental
- Price
- PFE $24.45
- WELL $169.39
- Analyst Decision
- PFE Hold
- WELL Buy
- Analyst Count
- PFE 13
- WELL 10
- Target Price
- PFE $29.75
- WELL $166.50
- AVG Volume (30 Days)
- PFE 46.5M
- WELL 2.4M
- Earning Date
- PFE 08-05-2025
- WELL 07-28-2025
- Dividend Yield
- PFE 7.10%
- WELL 1.74%
- EPS Growth
- PFE N/A
- WELL 67.69
- EPS
- PFE 1.89
- WELL 1.76
- Revenue
- PFE $63,833,000,000.00
- WELL $9,277,824,000.00
- Revenue This Year
- PFE N/A
- WELL $25.89
- Revenue Next Year
- PFE N/A
- WELL $12.06
- P/E Ratio
- PFE $12.79
- WELL $96.39
- Revenue Growth
- PFE 13.53
- WELL 31.96
- 52 Week Low
- PFE $20.92
- WELL $114.37
- 52 Week High
- PFE $30.43
- WELL $171.09
- Technical
- Relative Strength Index (RSI)
- PFE 50.21
- WELL 72.23
- Support Level
- PFE $23.86
- WELL $168.78
- Resistance Level
- PFE $24.89
- WELL $171.09
- Average True Range (ATR)
- PFE 0.49
- WELL 2.66
- MACD
- PFE -0.04
- WELL 0.58
- Stochastic Oscillator
- PFE 52.74
- WELL 95.18
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
About WELL Welltower Inc.
Welltower owns a diversified healthcare portfolio of 2,336 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.